Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi S.A. | Milano | Salute | Prodotti farmaceutici | 128,27 Mrd € | 14,1x | -0,6 | 101,66 € | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Gilead Sciences | Milano | Salute | Prodotti farmaceutici | 92,61 Mrd € | 98x | -1,23 | 73,98 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Merck | Milano | Salute | Prodotti farmaceutici | 69,56 Mrd € | 20,9x | -1,17 | 101,40 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Merck | Milano | Salute | Prodotti farmaceutici | 69,30 Mrd € | 26,4x | -1,76 | 159,95 € | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Bayer AG | Milano | Salute | Prodotti farmaceutici | 29,36 Mrd € | -23,2x | 0,12 | 29,92 € | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Recordati | Milano | Salute | Prodotti farmaceutici | 10,39 Mrd € | 27x | -69,02 | 50,80 € | 0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 4,9% Rialzo | Fai l’upgrade a Pro+ | |
Pharmanutra | Milano | Salute | Prodotti farmaceutici | 559,18 Mln € | 38,6x | 3,93 | 58,20 € | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 39,9% Rialzo | Fai l’upgrade a Pro+ | |
Shedir Pharma | Milano | Salute | Prodotti farmaceutici | 42,95 Mln € | 7,9x | -1,51 | 3,88 € | 2,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Laboratorio Farmaceutico Erfo | Milano | Salute | Prodotti farmaceutici | 8,58 Mln € | 17,6x | -1,09 | 1 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 47% Rialzo | Fai l’upgrade a Pro+ | |
Friulchem | Milano | Salute | Prodotti farmaceutici | 4,92 Mln € | 167,9x | 0,82 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 46,3% Rialzo | Fai l’upgrade a Pro+ |